|
1
|
Deshpande AM and Wong DT: Molecular
mechanisms of head and neck cancer. Expert Rev Anticancer Ther.
8:799–809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsantoulis PK, Kastrinakis NG, Tourvas AD,
Laskaris G and Gorgoulis VG: Advances in the biology of oral
cancer. Oral Oncol. 43:523–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan S, Tang QL, Lin YJ, Chen WL, Li JS,
Huang ZQ, Yang ZH, Wang YY, Zhang DM, Wang HJ, et al: A review of
clinical and histological parameters associated with contralateral
neck metastases in oral squamous cell carcinoma. Int J Oral Sci.
3:180–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khan N and Mukhtar H: Cancer and
metastasis: Prevention and treatment by green tea. Cancer
Metastasis Rev. 29:435–445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ying H, Biroc SL, Li WW, Alicke B, Xuan
JA, Pagila R, Ohashi Y, Okada T, Kamata Y and Dinter H: The Rho
kinase inhibitor fasudil inhibits tumor progression in human and
rat tumor models. Mol Cancer Ther. 5:2158–2164. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Woessner JF Jr: Matrix metalloproteinases
and their inhibitors in connective tissue remodeling. FASEB J.
5:2145–2154. 1991.PubMed/NCBI
|
|
7
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Velinov N, Poptodorov G, Gabrovski N and
Gabrovski S: The role of matrixmetalloproteinases in the tumor
growth and metastasis. Khirurgiia (Sofiia). 44–49. 2010.(In
Bulgarian).
|
|
9
|
Ram M, Sherer Y and Shoenfeld Y: Matrix
metalloproteinase-9 and autoimmune diseases. J Clin Immunol.
26:299–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brinckerhoff CE and Matrisian LM: Matrix
metalloproteinases: A tail of a frog that became a prince. Nat Rev
Mol Cell Biol. 3:207–214. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Itoh Y and Nagase H: Matrix
metalloproteinases in cancer. Essays Biochem. 38:21–36. 2002.
View Article : Google Scholar
|
|
12
|
Helbig G, Christopherson KW II,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-kappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koyama S: Differential expression of
intracellular apoptotic signaling molecules in tumor and
tumor-infiltrating lymphocytes during development of invasion
and/or metastasis of gastric carcinoma. Dig Dis Sci. 48:2290–2300.
2003. View Article : Google Scholar
|
|
14
|
Pai SI and Westra WH: Molecular pathology
of head and neck cancer: Implications for diagnosis, prognosis, and
treatment. Annu Rev Pathol. 4:49–70. 2009. View Article : Google Scholar
|
|
15
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang CY, Mayo MW and Baldwin AS Jr: TNF-
and cancer therapy-induced apoptosis: Potentiation by inhibition of
NF-kappaB. Science. 274:784–787. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aggarwal BB: Nuclear factor-kappaB: The
enemy within. Cancer Cell. 6:203–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ghosh S and Karin M: Missing pieces in the
NF-kappaB puzzle. Cell. 109(Suppl): S81–S96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McNulty SE, Tohidian NB and Meyskens FL
Jr: RelA, p50 and inhibitor of kappa B alpha are elevated in human
metastatic melanoma cells and respond aberrantly to ultraviolet
light B. Pigment Cell Res. 14:456–465. 2001. View Article : Google Scholar
|
|
20
|
Park BK, Zhang H, Zeng Q, Dai J, Keller
ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, et al: NF-kappaB in
breast cancer cells promotes osteolytic bone metastasis by inducing
osteoclastogenesis via GM-CSF. Nat Med. 13:62–69. 2007. View Article : Google Scholar
|
|
21
|
Sasaki N, Morisaki T, Hashizume K, Yao T,
Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka
M, et al: Nuclear factor-kappaB p65 (RelA) transcription factor is
constitutively activated in human gastric carcinoma tissue. Clin
Cancer Res. 7:4136–4142. 2001.PubMed/NCBI
|
|
22
|
Shishodia S and Aggarwal BB: Nuclear
factor-kappaB activation mediates cellular transformation,
proliferation, invasion angiogenesis and metastasis of cancer.
Cancer Treat Res. 119:139–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liptay S, Weber CK, Ludwig L, Wagner M,
Adler G and Schmid RM: Mitogenic and antiapoptotic role of
constitutive NF-kappaB/Rel activity in pancreatic cancer. Int J
Cancer. 105:735–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aguirre Ghiso JA, Alonso DF, Farías EF,
Gomez DE and de Kier Joffè EB: Deregulation of the signaling
pathways controlling urokinase production. Its relationship with
the invasive phenotype. Eur J Biochem. 263:295–304. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Westermarck J and Kähäri VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999.
|
|
26
|
Mannello F, Tonti G and Papa S: Matrix
metalloproteinase inhibitors as anticancer therapeutics. Curr
Cancer Drug Targets. 5:285–298. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu FS, Huang AC, Yang JS, Yu CS, Lu CC,
Chiang JH, Chiu CF and Chung JG: Safrole induces cell death in
human tongue squamous cancer SCC-4 cells through
mitochondria-dependent caspase activation cascade apoptotic
signaling pathways. Environ Toxicol. 27:433–444. 2012. View Article : Google Scholar
|
|
28
|
Jao HY, Yu FS, Yu CS, Chang SJ, Liu KC,
Liao CL, Ji BC, Bau DT and Chung JG: Suppression of the migration
and invasion is mediated by triptolide in B16F10 mouse melanoma
cells through the NF-kappaB-dependent pathway. Environ Toxicol. Sep
29–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang YM, Velmurugan BK, Kuo WW, Chen YS,
Ho TJ, Tsai CT, Ye CX, Tsai CH, Tsai FJ and Huang CY: Inhibitory
effect of alpinate Oxyphyllae fructus extracts on Ang II-induced
cardiac pathological remodeling-related pathways in H9c2
cardiomyoblast cells. Biomedicine. 3:148–152. 2013. View Article : Google Scholar
|
|
30
|
Lai KC, Hsu SC, Kuo CL, Ip SW, Yang JS,
Hsu YM, Huang HY, Wu SH and Chung JG: Phenethyl isothiocyanate
inhibited tumor migration and invasion via suppressing multiple
signal transduction pathways in human colon cancer HT29 cells. J
Agric Food Chem. 58:11148–11155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai WW, Hsu SC, Chueh FS, Chen YY, Yang
JS, Lin JP, Lien JC, Tsai CH and Chung JG: Quercetin inhibits
migration and invasion of SAS human oral cancer cells through
inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling
pathways. Anticancer Res. 33:1941–1950. 2013.PubMed/NCBI
|
|
32
|
Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL,
Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration
and invasion of human A549 lung cancer cells through the inhibition
of matrix metalloproteinase-2 and -9 and Vascular Endothelial
Growth Factor (VEGF). Cancer Lett. 285:127–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin MC, Tsai SY, Wang FY, Liu FH, Syu JN
and Tang FY: Leptin induces cell invasion and the upregulation of
matrilysin in human colon cancer cells. Biomedicine. 3:174–180.
2013. View Article : Google Scholar
|
|
34
|
Lin HJ, Su CC, Lu HF, Yang JS, Hsu SC, Ip
SW, Wu JJ, Li YC, Ho CC, Wu CC, et al: Curcumin blocks migration
and invasion of mouse-rat hybrid retina ganglion cells (N18)
through the inhibition of MMP-2, -9, FAK, Rho A and Rock-1 gene
expression. Oncol Rep. 23:665–670. 2010.PubMed/NCBI
|
|
35
|
Liu KC, Huang AC, Wu PP, Lin HY, Chueh FS,
Yang JS, Lu CC, Chiang JH, Meng M and Chung JG: Gallic acid
suppresses the migration and invasion of PC-3 human prostate cancer
cells via inhibition of matrix metalloproteinase-2 and -9 signaling
pathways. Oncol Rep. 26:177–184. 2011.PubMed/NCBI
|
|
36
|
Lu KW, Chen JC, Lai TY, Yang JS, Weng SW,
Ma YS, Lu PJ, Weng JR, Chueh FS, Wood WG, et al: Gypenosides
inhibits migration and invasion of human oral cancer SAS cells
through the inhibition of matrix metalloproteinase-2 -9 and
urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
Hum Exp Toxicol. 30:406–415. 2011. View Article : Google Scholar
|
|
37
|
Lu HF, Tung WL, Yang JS, Huang FM, Lee CS,
Huang YP, Liao WY, Chen YL and Chung JG: In vitro suppression of
growth of murine WEHI-3 leukemia cells and in vivo promotion of
phagocytosis in a leukemia mice model by indole-3-carbinol. J Agric
Food Chem. 60:7634–7643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Q, Han Y, Wang C, Shan S, Wang Y, Zhang
J and Ren T: MicroRNA-125b promotes tumor metastasis through
targeting tumor protein 53-induced nuclear protein 1 in patients
with non-small-cell lung cancer. Cancer Cell Int. 15:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu SH, Hsiao YT, Kuo CL, Yu FS, Hsu SC, Wu
PP, Chen JC, Hsia TC, Liu HC, Hsu WH, et al: Bufalin inhibits
NCI-H460 human lung cancer cell metastasis in vitro by inhibiting
MAPKs, MMPs, and NF-κB pathways. Am J Chin Med. 43:1247–1264. 2015.
View Article : Google Scholar
|
|
40
|
Lin ML, Chung JG, Lu YC, Yang CY and Chen
SS: Rhein inhibits invasion and migration of human nasopharyngeal
carcinoma cells in vitro by down-regulation of matrix
metalloproteinases-9 and vascular endothelial growth factor. Oral
Oncol. 45:531–537. 2009. View Article : Google Scholar
|
|
41
|
Köhrmann A, Kammerer U, Kapp M, Dietl J
and Anacker J: Expression of matrix metalloproteinases (MMPs) in
primary human breast cancer and breast cancer cell lines: New
findings and review of the literature. BMC Cancer. 9:1882009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: Trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Folgueras AR, Pendás AM, Sánchez LM and
López-Otín C: Matrix metalloproteinases in cancer: From new
functions to improved inhibition strategies. Int J Dev Biol.
48:411–424. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar :
|
|
45
|
Schütz A, Schneidenbach D, Aust G,
Tannapfel A, Steinert M and Wittekind C: Differential expression
and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal
cells of squamous cell carcinomas of the lung. Tumour Biol.
23:179–184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu X, Zhu Y, Yan H, Liu B, Li Y, Zhou Q
and Xu K: Isothiocyanates induce oxidative stress and suppress the
metastasis potential of human non-small cell lung cancer cells. BMC
Cancer. 10:2692010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Weng CJ and Yen GC: The in vitro and in
vivo experimental evidences disclose the chemopreventive effects of
Ganoderma lucidum on cancer invasion and metastasis. Clin Exp
Metastasis. 27:361–369. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rodríguez-Berriguete G, Fraile B,
Martínez-Onsurbe P, Olmedilla G, Paniagua R and Royuela M: MAP
Kinases and Prostate Cancer. J Signal Transduct. 2012:1691702012.
View Article : Google Scholar
|
|
49
|
Yu T, Wu Y, Helman JI, Wen Y, Wang C and
Li L: CXCR4 promotes oral squamous cell carcinoma migration and
invasion through inducing expression of MMP-9 and MMP-13 via the
ERK signaling pathway. Mol Cancer Res. 9:161–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Conley-LaComb MK, Saliganan A, Kandagatla
P, Chen YQ, Cher ML and Chinni SR: PTEN loss mediated Akt
activation promotes prostate tumor growth and metastasis via
CXCL12/CXCR4 signaling. Mol Cancer. 12:852013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA
and Chen JH: Inhibitory effects of andrographolide on migration and
invasion in human non-small cell lung cancer A549 cells via
down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol.
632:23–32. 2010. View Article : Google Scholar
|
|
52
|
Yang SF, Chen MK, Hsieh YS, Yang JS,
Zavras AI, Hsieh YH, Su SC, Kao TY, Chen PN and Chu SC:
Antimetastatic effects of Terminalia catappa L. on oral cancer via
a down-regulation of metastasis-associated proteases. Food Chem
Toxicol. 48:1052–1058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim D, Kim S, Koh H, Yoon SO, Chung AS,
Cho KS and Chung J: Akt/PKB promotes cancer cell invasion via
increased motility and metalloproteinase production. FASEB J.
15:1953–1962. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Prabhu L, Mundade R, Korc M, Loehrer PJ
and Lu T: Critical role of NF-κB in pancreatic cancer. Oncotarget.
5:10969–10975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vayalil PK and Katiyar SK: Treatment of
epigallocatechin-3-gal-late inhibits matrix metalloproteinases-2
and -9 via inhibition of activation of mitogen-activated protein
kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145
cells. Prostate. 59:33–42. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cheung LW, Leung PC and Wong AS:
Gonadotropin-releasing hormone promotes ovarian cancer cell
invasiveness through c-Jun NH2-terminal kinase-mediated activation
of matrix metalloproteinase (MMP)-2 and MMP-9. Cancer Res.
66:10902–10910. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sweeney C, Li L, Shanmugam R,
Bhat-Nakshatri P, Jayaprakasan V, Baldridge LA, Gardner T, Smith M,
Nakshatri H and Cheng L: Nuclear factor-kappaB is constitutively
activated in prostate cancer in vitro and is overexpressed in
prostatic intraepithelial neoplasia and adenocarcinoma of the
prostate. Clin Cancer Res. 10:5501–5507. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Price JT, Tiganis T, Agarwal A, Djakiew D
and Thompson EW: Epidermal growth factor promotes MDA-MB-231 breast
cancer cell migration through a phosphatidylinositol 3′-kinase and
phospholipase C-dependent mechanism. Cancer Res. 59:5475–5478.
1999.PubMed/NCBI
|
|
59
|
Noma N, Asagiri M, Takeiri M, Ohmae S,
Takemoto K, Iwaisako K, Minato N, Maeda-Yamamoto M, Simizu S and
Umezawa K: Inhibition of MMP-2-mediated mast cell invasion by NF-κB
inhibitor DHMEQ in mast cells. Int Arch Allergy Immunol. 166:84–90.
2015. View Article : Google Scholar
|
|
60
|
Arlt A, Gehrz A, Müerköster S, Vorndamm J,
Kruse ML, Fölsch UR and Schäfer H: Role of NF-kappaB and Akt/PI3K
in the resistance of pancreatic carcinoma cell lines against
gemcitabine-induced cell death. Oncogene. 22:3243–3251. 2003.
View Article : Google Scholar
|
|
61
|
Chen PS, Shih YW, Huang HC and Cheng HW:
Diosgenin, a steroidal saponin, inhibits migration and invasion of
human prostate cancer PC-3 cells by reducing matrix
metalloproteinases expression. PLoS One. 6:e201642011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Eccles SA, Box GM, Court WJ, Bone EA,
Thomas W and Brown PD: Control of lymphatic and hematogenous
metastasis of a rat mammary carcinoma by the matrix
metalloproteinase inhibitor batimastat (BB-94). Cancer Res.
56:2815–2822. 1996.PubMed/NCBI
|
|
63
|
Wang W, Abbruzzese JL, Evans DB, Larry L,
Cleary KR and Chiao PJ: The nuclear factor-kappa B RelA
transcription factor is constitutively activated in human
pancreatic adenocarcinoma cells. Clin Cancer Res. 5:119–127.
1999.PubMed/NCBI
|
